Eight US Manufacturers Selected to Make NASA COVID-19 Ventilator
On Mar. 25, 2020, NASA’s Jet Propulsion Laboratory (JPL) in Southern California announced that after receiving more than…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Medicine | NIH | Non-Profit Research | Therapeutics
National Library of Medicine expanded access to coronavirus literature through PubMed Central
On Mar. 25, 2020, the National Library of Medicine (NLM), part of the National Institutes of Health, announced…
Biotechnology | COVID-19 | Diagnostics | Life Science News | Medical Device | Medicine | Therapeutics | Vaccine
Life sciences companies commit to fight against COVID-19 pandemic with Bill & Melinda Gates Foundation
On Mar. 25, 2020, a consortium of life sciences companies announced an important collaboration to accelerate the development,…
Mateon reported positive results for multiple COVID-19 drug candidates
On Mar. 25, 2020, Mateon Therapeutics announced an update on its rapid antiviral response program targeting coronaviruses, initially…
Xencor and Vir Biotech announced license agreement for use of Xtend XmAb antibody technology to treat COVID-19
On Mar. 25, 2020, Xencor announced a technology license agreement with Vir Biotech in which Vir will have…
The Jackson Laboratory expediting unique transgenic mouse model for COVID-19 research
On Mar. 25, 2020, the Jackson Laboratory (JAX) announced it was working to ensure that the worldwide research…
Partner Therapeutics announced initiation of clinical trial to evaluate Leukine in patients with COVID-19
On Mar. 24, 2020, Partner Therapeutics that Leukine (sargramostim, rhu-GM-CSF) is being assessed in the SARPAC trial (sargramostim…
Novavax NanoFlu achieved all primary endpoints in phase 3 clinical trial
On Mar. 24, 2020, Novavax announced positive top-line results of its pivotal Phase 3 clinical trial of NanoFlu,…
City of Hope researchers developing COVID-19 vaccine
On Mar. 24, 2020, City of Hope announced that it had employed its vast expertise using the immune…
U of A research projects shared $58 million in federal funding
On Mar. 24, 2020, the University of Alberta (U of A) announced that a Public health study was…
3M partnered with Ford to help further accelerate COVID-19 response
On Mar. 24, 2020, 3M and Ford Motor announced a partnership to increase the production of 3M’s powered…
MatMaCorp’s DNA and RNA testing platform could help protect the U.S. pork supply from African swine fever
On Mar. 24, 2020, MatMaCorp announced the successful evaluation of a genetic test to detect African swine fever…
The Simmons Cancer Center joined elite National Comprehensive Cancer Network
On Mar. 24, 2020, the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern announced it had joined…
COVID-19 | Diagnostics | Life Science News | NIH | Non-Profit Research | Therapeutics | U.S. Congress | Vaccine
NIH online resources support COVID-19 workers training to protect their own health
On Mar. 23, 2020, the National Institutes of Health (NIH) announced that it had launched an important online…
Cumberland Pharma Announced Initiative To Expand Availability Of VIBATIV® To Treat Hospital-Acquired & Ventilator-Associated Pneumonia Resulting From Coronavirus Infections
On Mar. 23, 2020, Cumberland Pharmaceuticals announced a national initiative to support the treatment of patients with hospital-acquired…
Emory’s DRIVE, Ridgeback partnered for drug versus coronavirus
On Mar. 23, 2020, Drug Innovation Ventures at Emory (DRIVE), and Ridgeback Biotherapeutics announced a collaboration to rapidly…
Soligenix and University of Hawaii at Manoa initiate work on novel Coronavirus vaccine for COVID-19
On Mar. 23, 2020, Soligenix announced that its ongoing collaboration with the University of Hawaii at Manoa (UH…
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Life Science News | Therapeutics | Vaccine
CSL Group to help battle Coronavirus
On Mar. 23, 2020, CSL announced that it was exploring development of a hyperimmune serum that could be…
Mount Sinai developing an ‘end-to-end’ diagnostics solution for COVID-19
On Mar. 23, 2020, an expert team of researchers and clinicians in microbiology, virology, pathology, molecular science, and…
New study expanded understanding of influenza-associated complications
On Mar. 20, 2020, a study was published in JAMA that expands the understanding of influenza-associated complications. Influenza…
The CDC reported the pace of tuberculosis decline in the U.S. slowed in recent years
On Mar. 20, 2020, the Centers for Disease Control and Prevention (CDC) reported that tuberculosis (TB) incidence in…
Cardax releases white paper on the potential role of Astaxanthin in treatment of Coronavirus disease
On Mar. 20, 2020, Cardax released a white paper outlining the potential role of astaxanthin in the treatment…
FDA granted Bellerophon emergency expanded access for INOpulse for treatment of COVID-19 virus
On Mar. 20, 2020, Bellerophon Therapeutics announced the U.S. Food and Drug Administration (FDA) had granted emergency expanded…
Amneal accelerated distribution and production of hydroxychloroquine sulfate to meet potential needs of COVID-19 patients
On Mar. 20, 2020, Amneal Pharma announced that it was responding to the national COVID-19 health emergency by…
Adaptive Biotechnologies and Microsoft expanded partnership to decode COVID-19 immune response and provide open data access
On Mar. 20, 2020, Adaptive Biotechnologies and Microsoft announced they were leveraging their existing partnership mapping population-wide adaptive…
COVID-19 | FDA | Medicine | Therapeutics
Mylan ramped up U.S. manufacturing of hydroxychloroquine sulfate tablets to meet potential COVID-19 patient needs
On Mar. 19, 2020, Mylan announced it had restarted production of hydroxychloroquine sulfate tablets at its West Virginia…
FDA approved Epclusa (Sofosbuvir/Velpatasvir) for children with Chronic Hepatitis C infection
On Mar. 19, 2020, Gilead Sciences announced the U.S. Food and Drug Administration (FDA) had approved a supplemental…
Cumberland Pharmaceuticals announced initiative to expand availability of Caldolor to treat fevers associated with Coronavirus Infections
On Apr. 1, 2020, Cumberland Pharma announced a national initiative to support hospitals and clinics that use Caldolor…
Teva donated potential COVID-19 treatment, hydroxychloroquine sulfate tablets to hospitals nationwide
On Mar. 19, 2020, Teva announced the immediate donation of more than 6 million doses of hydroxychloroquine sulfate…
Mateon to develop its OT-101, a phase 3 clinical drug candidate against COVID-19
On Mar. 18, 2020, Mateon Therapeutics reported significant progress in deploying its phase 3 clinical asset, OT-101, against…